Cargando…
Reassembly of Nucleosomes at the MLH1 Promoter Initiates Resilencing Following Decitabine Exposure
Hypomethylating agents reactivate tumor suppressor genes that are epigenetically silenced in cancer. Inevitably these genes are resilenced, leading to drug resistance. Using the MLH1 tumor suppressor gene as a model, we showed that decitabine-induced re-expression was dependent upon demethylation an...
Autores principales: | Hesson, Luke B., Patil, Vibha, Sloane, Mathew A., Nunez, Andrea C., Liu, Jia, Pimanda, John E., Ward, Robyn L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723495/ https://www.ncbi.nlm.nih.gov/pubmed/23935509 http://dx.doi.org/10.1371/journal.pgen.1003636 |
Ejemplares similares
-
Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patients
por: Sloane, Mathew A, et al.
Publicado: (2014) -
Lynch Syndrome Associated with Two MLH1 Promoter Variants and Allelic Imbalance of MLH1 Expression
por: Hesson, Luke B, et al.
Publicado: (2015) -
Defining the criteria for identifying constitutional epimutations
por: Sloane, Mathew A., et al.
Publicado: (2016) -
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
por: Gallitto, Matthew, et al.
Publicado: (2020) -
Reassembly of BEBC
Publicado: (1974)